The 20 Best Parathyroid Hyperplasia Doctors Near Me in Ypsilanti, MI

Beth Kimball is a General Surgeon practicing medicine in Ypsilanti, Michigan. Dr. Kimball is rated as a Distinguished provider by MediFind in the treatment of Parathyroid Hyperplasia. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Paget Disease of the Breast, Breast Cancer, Lymphadenectomy, and Parathyroidectomy.

Anita Repp is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Repp is rated as an Advanced provider by MediFind in the treatment of Parathyroid Hyperplasia. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Osteoporosis, Postmenopausal Osteoporosis, and Type 2 Diabetes (T2D).

Suma Amarnath is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Amarnath is rated as an Advanced provider by MediFind in the treatment of Parathyroid Hyperplasia. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Hyperthyroidism, Hypothyroidism, and Addison's Disease.

Dhammi Jayathilaka is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Jayathilaka is rated as an Advanced provider by MediFind in the treatment of Parathyroid Hyperplasia. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Thyroid Storm, Thyroid Nodule, Hyperthyroidism, and Hyperparathyroidism.

Wade Jodeh is an Endocrinologist practicing medicine in Ypsilanti, Michigan. Dr. Jodeh is rated as an Experienced provider by MediFind in the treatment of Parathyroid Hyperplasia. His clinical expertise encompasses Parathyroid Hyperplasia, Osteosclerosis Autosomal Dominant, Osteopetrosis, and Hypercalcemia.

Dr. Gauger is the William J. Fry Professor of Surgery in the Division of Endocrine Surgery. Dr. Gauger trained in General Surgery at the University of Michigan where he also completed fellowships in Extracorporeal Life Support and Surgical Critical Care. After graduation, he served as the T.S. Reeve International Fellow in Endocrine Surgery at the Royal North Shore Hospital in Sydney, Australia. He then returned to Michigan in 1999 to join the faculty in the Department of Surgery. Dr. Gauger specializes in the treatment of benign and malignant diseases of the thyroid, parathyroid, and adrenal glands in both adults and children. He also specializes in the treatment of endocrine tumors of the pancreas and intestines. He has a particular interest in the Multiple Endocrine Neoplasia Syndromes. Dr. Gauger is also a Professor of Learning Health Sciences and is deeply involved in graduate medical education issues. He serves as the Program Director for Surgery and leads the Norman W. Thompson Fellowship in Endocrine Surgery. He was also the founding Executive Director of the University of Michigan Clinical Simulation Center. Dr. Gauger is rated as a Distinguished provider by MediFind in the treatment of Parathyroid Hyperplasia. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Thyroid Cancer, Parathyroid Hyperplasia, Parathyroidectomy, and Thyroidectomy. Dr. Gauger is board certified in Surgery.

Dr. Susan Pitt, MD, MPHS is an Associate Professor of Surgery and Director of the Endocrine Surgery Health Services Research Program in the Department of Surgery at Michigan Medicine. Dr. Pitt graduated Magna Cum Laude with a B.A. in psychology from Boston College in Chestnut Hill, MA. She received her medical degree from the Medical College of Wisconsin and a Masters degree in Population Health Science from Washington University in St. Louis which was supported by a scholarship from the BJC Healthcare Institute for Public Health. Dr. Pitt completed her general surgery residency at Washington University in St. Louis with Alpha Omega Alpha honors and was both the resident representative and administrative chief resident. During a two-year post-doctoral research fellowship at the University of Wisconsin, she was awarded a Ruth L. Kirschstein T32 training grant from the National Institutes of Health and the American College of Surgeons Resident Research Scholarship to study signaling pathways in neuroendocrine cancers. Following residency, Dr. Pitt completed an Endocrine Surgery Fellowship at Brigham & Women’s Hospital in Boston, MA before serving as an Assistant Professor of Surgery for six years at the University of Wisconsin in Madison, WI. Dr. Pitt joined the faculty of the University of Michigan in 2021.Dr. Pitt has received multiple awards for her clinical, research, and teaching efforts including the American Medical Women’s Association Exceptional Mentor Award in 2018 and an award from the University of Wisconsin-Madison Women in Science & Engineering Leadership Institute. She is a Fellow of the American College of Surgeons and active member of multiple organizations including the Association of Academic Surgery, Society of University Surgeons, American Association of Endocrine Surgeons, American Thyroid Association, Surgical Outcomes Club, Association of Women Surgeons, and Society for Medical Decision Making.Clinical Specialization: Dr. Pitt’s clinical interests include surgical diseases of the endocrine system including the thyroid, parathyroid, and adrenal glands. She has a particular interest and experience in the diagnosis and treatment of papillary thyroid cancer, functional adrenal tumors, and complex parathyroid disease. Dr. Pitt works closely with her endocrine oncology partners to provide excellent patient care and outcomes. Dr. Pitt is rated as a Distinguished provider by MediFind in the treatment of Parathyroid Hyperplasia. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Hyperparathyroidism, Papillary Thyroid Cancer, Thyroidectomy, and Parathyroidectomy. Dr. Pitt is board certified in Surgery.

Dr. Chun is a physician-scientist, who practices general endocrinology, including diabetes, thyroid diseases, and metabolic syndrome. His research is focused on the cellular and molecular mechanism of obesity, diabetes, and inflammatory and fibrotic tissue damages in endocrine disorders, such as Graves’ eye disease. Dr. Chun is rated as an Advanced provider by MediFind in the treatment of Parathyroid Hyperplasia. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Osteitis Fibrosa, and Familial Isolated Hyperparathyroidism. Dr. Chun is board certified in Endocrinology, Diabetes & Metabolism and Internal Medicine.

Cristina Nieves is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Nieves is rated as an Advanced provider by MediFind in the treatment of Parathyroid Hyperplasia. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Toxic Nodular Goiter, Thyroid Storm, Type 2 Diabetes (T2D), and Low Blood Sugar. Dr. Nieves is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Daniyeh Khurram is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Khurram is rated as an Advanced provider by MediFind in the treatment of Parathyroid Hyperplasia. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Osteitis Fibrosa, Thrombectomy, and Endoscopy. Dr. Khurram is board certified in Endocrinology, Diabetes & Metabolism and Internal Medicine.

Dr. Bodnar is the Assistant Chief of Endocrinology & Metabolism at Ann Arbor VA Health System. He is a graduate of the University of Michigan Medical School, and completed Internal Medicine Residency and Chief Residency, as well as his Fellowship in Endocrinology at Michigan Medicine. From 2014-2021 he was in private practice at Ann Arbor Endocrinology & Diabetes and was a Key Clinical Faculty Member in the St. Joseph Mercy Ann Arbor Internal Medicine Residency. Dr. Bodnar is rated as an Experienced provider by MediFind in the treatment of Parathyroid Hyperplasia. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Osteoporosis, and Pituitary Tumor. Dr. Bodnar is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors. Dr. Else is rated as an Experienced provider by MediFind in the treatment of Parathyroid Hyperplasia. He is also highly rated in 105 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Adrenal Gland Adenoma, Neuroendocrine Tumor, and Thyroidectomy. Dr. Else is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

David Hughes is a General Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Hughes is rated as a Distinguished provider by MediFind in the treatment of Parathyroid Hyperplasia. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Familial Isolated Hyperparathyroidism, Parathyroid Hyperplasia, Osteitis Fibrosa, Parathyroidectomy, and Thymectomy.

Arqam Zia is an Endocrinologist practicing medicine in Canton, Michigan. He has been practicing medicine for over 30 years. Dr. Zia is rated as an Experienced provider by MediFind in the treatment of Parathyroid Hyperplasia. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Addison's Disease, Secondary Adrenal Insufficiency, and Triple A Syndrome. Dr. Zia is board certified in American Board Of Internal Medicine. Dr. Zia is currently accepting new patients.

Zahrae Sandouk M.D., is a Clinical Assistant Professor, board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism and a graduate from Henry Ford Hospital and Cleveland Clinic who has an interest in Diabetes mellitus, Diabetes complications, Cystic Fibrosis related Diabetes, Pituitary disorders, Prolactinoma, Hypopituitarism, Thyroid disorders, Bone and calcium disorders, Adrenal and Osteoporosis. Also the medical director of the Endocrine Testing Unity at the University of Michigan where dynamic studies are performed and is also part of the Cystic Fibrosis multidisciplinary team. Dr. Sandouk is rated as an Experienced provider by MediFind in the treatment of Parathyroid Hyperplasia. She is also highly rated in 39 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Adrenal Insufficiency Pediatric, Type 2 Diabetes (T2D), and Thyroid Nodule. Dr. Sandouk is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Gregory Clines is an Associate Professor of Internal Medicine in the Division of Metabolism, Endocrinology & Diabetes (MEND) at the University of Michigan. He received his MD and PhD degrees at the University of Texas Southwestern Medical Center at Dallas. He then completed internal medicine training at Duke University and an endocrinology fellowship at the University of Virginia. Before joining the University of Michigan in 2013, he was on the faculty at the University of Virginia and the University of Alabama at Birmingham.Dr. Clines has been studying and thinking about bone diseases for nearly 30 years. His basic science laboratory studies how novel factors such as hypoxia, androgens, endothelins, Wnt signaling, and other factors regulate the osteoblast-cancer cell synergy in bone metastasis. His other research interests include understanding how sex steroids regulate skeletal size and shape, and the development of novel imaging techniques to assess bone quality.His clinical interests include metabolic and genetic bone diseases as well as general endocrinology. Dr. Clines sees patients at the Metabolism, Endocrinology & Diabetes Clinic (Metabolic Bone Disease Clinic) and at the Ann Arbor Veterans Affairs Medical Center. Dr. Clines is rated as an Experienced provider by MediFind in the treatment of Parathyroid Hyperplasia. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Osteoporosis, Paget's Disease of Bone, Postmenopausal Osteoporosis, Thyroidectomy, and Orchiectomy. Dr. Clines is board certified in Endocrinology, Diabetes & Metabolism.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Douyon is rated as an Experienced provider by MediFind in the treatment of Parathyroid Hyperplasia. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Dr. Lynn Ang is currently a Clinical Associate Professor in the Metabolism, Endocrinology, and Diabetes Division, Internal Medicine Department at University of Michigan. Dr. Ang is one of the principle attending physicians for the Diabetes Transition Program. Dr. Ang’s clinical and research interests are in the fields of implementing optimal management of inpatient and outpatient hyperglycemia, creating protocols for inpatient hospital guidelines, identifying biomarkers to predict the development or progression of diabetic complications, detecting the earliest stages of complications to prevent progression of diseases, and developing sensitive diagnostic methods/treatment for those complications. Dr. Ang also serves as a Co-Director of Hospital Intensive Insulin Program. Dr. Ang has been actively involving in teaching internal medicine and podiatry residents, endocrinology fellows, and medical students in both ambulatory and inpatient clinical settings. She was a recipient of Goran Sundkvist Young Investigators Award for Clinical Science 2022. Dr. Ang is rated as an Experienced provider by MediFind in the treatment of Parathyroid Hyperplasia. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Neuropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Ang is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA). Dr. Esfandiari is rated as an Experienced provider by MediFind in the treatment of Parathyroid Hyperplasia. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Gastric Bypass, and Thyroidectomy. Dr. Esfandiari is board certified in Endocrinology, Diabetes & Metabolism.

Dr. Kraftson specializes in treating patients with excess weight/obesity in addition to seeing patients with general endocrinologic conditions. He was inducted into the Clinical Excellence Society in 2021. He is the Director of the Weight Navigation Program & the Director of the Post Bariatric Endocrinology Clinic. Dr. Kraftson's research, focuses on gaining a better understanding of delivering effective care for individuals with obesity. In addition to these interests, Dr. Kraftson is actively involved in medical education and is the Associate Program Director for the M.E.N.D. Endocrinology Fellowship. Dr. Kraftson is rated as an Experienced provider by MediFind in the treatment of Parathyroid Hyperplasia. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Obesity, Malnutrition, Type 2 Diabetes (T2D), Gastric Bypass, and Sleeve Gastrectomy. Dr. Kraftson is board certified in Endocrinology, Diabetes & Metabolism.